UPDATE: Credit Suisse Initiates Outperform, $47 Target on Life Technologies

Credit Suisse initiates coverage on Life Technologies

with an Outperform rating and $47 target price, as the company provides diversity and expansion into applied and emerging markets. Credit Suisse says, “We value the diversity that LIFE offers as well as its recurrent revenue stream and expansion into applied and emerging markets. LIFE is not all about defense, however, as our due diligence and insights from a proprietary research survey highlight the long-term potential for LIFE's Personal Genome Machine (

) in the benchtop DNA sequencing market.” LIFE closed at $38.32 per share on Wednesday.